Corrigendum to “Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice,” [Biomed. Pharmacother. 158 (2023) 114069] - 21/02/26

Yifang Li ^a, Gang Zheng ^b, Ekaterina Salimova ^b, Brad R.S. Broughton ^a, Sharon D. Ricardo ^c, Michael de Veer ^b, Chrishan S. Samuel ^{a, c, d, ⁎}

^a Cardiovascular Disease Program, Monash Biomedicine Discovery Institute (BDI) and Department of Pharmacology, Monash University, Clayton, Victoria, Australia 

^b Monash Biomedical Imaging, Monash University, Clayton, Victoria, Australia 

^c Stem Cells and Development Program, Monash Biomedicine Discovery Institute (BDI) and Department of Pharmacology, Monash University, Clayton, Victoria, Australia 

^d Department of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, Victoria, Australia 

^⁎ Corresponding author at: Cardiovascular Disease Program, Monash Biomedicine Discovery Institute (BDI) and Department of Pharmacology, Monash University, Clayton, Victoria, Australia. Cardiovascular Disease Program, Monash Biomedicine Discovery Institute (BDI) and Department of Pharmacology, Monash University Clayton Victoria Australia

Le texte complet de cet article est disponible en PDF.